The goal of this work is to determine whether we can identify the children with acute lymphoblastic leukemia (ALL) who will have cognitive and academic problems using markers of central nervous system (CNS) injury obtained during treatment. Although declines in cognitive and academic function have been linked to CNS treatment in many studies, some ALL survivors exhibit significant declines while others do not. What accounts for this variability? Our recent findings suggest that changes in CSF phospholipid composition during treatment are related to subsequent cognitive and academic function. Based on our preliminary studies and available literature, the investigators believe that CNS injury has both direct and indirect effects on cognitive and academic function and that one indirect effect is a result of the impact of CNS injury on CNS processing speed. Thus, they will examine relationships between CSF markers of CNS injury, processing speed, and cognitive and academic abilities using latent variable and structural equation models. This prospective longitudinal study will follow 90 children with ALL who are age 3 to 13 years of age at diagnosis and treated according to Pediatric Oncology Group Protocol with triple intrathecal chemotherapy and intermediate dose systemic methotrexate. CSF concentration of 3 phospholipids (sphingomyelin, phosphatidylcholine, lysophosphaditylcholine) and cardiolipin will be used as markers of CNS injury. Cognitive and academic abilities will be evaluated at diagnosis and 1, 2,and 3 years after diagnosis. The investigators will use growth curve analysis to estimate each child's initial status and rate of change on cognitive and academic measures. They hypothesize that there will be (1) A significant negative relationship between CSF markers and performance on cognitive and academic measures; (2) A significant negative relationship between CSF markers and processing speed; and (3) A significant positive relationship between processing speed and cognitive and academic performance. Variables that may be related to cognitive outcomes will also be included in measurement models. These include the child's age at diagnosis or evaluation, sex, baseline abilities, school attendance and educational services and socioeconomic status. A sibling comparison group will be followed to allow estimation of loss of abilities associated with ALL and its treatment and identify cognitive abilities that may be particularly vulnerable. If the study can identify children at risk for cognitive and academic problems, those most in need of assistance can be provided with educational services and evaluation interventions.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD037816-05
Application #
6603327
Study Section
Behavioral Medicine Study Section (BEM)
Program Officer
Haverkos, Lynne
Project Start
1999-09-01
Project End
2005-06-30
Budget Start
2003-07-01
Budget End
2005-06-30
Support Year
5
Fiscal Year
2003
Total Cost
$397,393
Indirect Cost
Name
University of Arizona
Department
Pediatrics
Type
Schools of Medicine
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Krull, Kevin R; Hockenberry, Marilyn J; Miketova, Petra et al. (2013) Chemotherapy-related changes in central nervous system phospholipids and neurocognitive function in childhood acute lymphoblastic leukemia. Leuk Lymphoma 54:535-40
Stenzel, Stephanie L; Krull, Kevin R; Hockenberry, Marilyn et al. (2010) Oxidative stress and neurobehavioral problems in pediatric acute lymphoblastic leukemia patients undergoing chemotherapy. J Pediatr Hematol Oncol 32:113-8
Caron, Joshua E; Krull, Kevin R; Hockenberry, Marilyn et al. (2009) Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 53:551-6
Moore, Ida M Ki; Miketova, Petra; Hockenberry, Marilyn et al. (2008) Methotrexate-induced alterations in beta-oxidation correlate with cognitive abilities in children with acute lymphoblastic leukemia. Biol Res Nurs 9:311-9
Carey, M E; Haut, M W; Reminger, S L et al. (2008) Reduced frontal white matter volume in long-term childhood leukemia survivors: a voxel-based morphometry study. AJNR Am J Neuroradiol 29:792-7
Carey, Marissa E; Hockenberry, Marilyn J; Moore, Ida M et al. (2007) Brief report: effect of intravenous methotrexate dose and infusion rate on neuropsychological function one year after diagnosis of acute lymphoblastic leukemia. J Pediatr Psychol 32:189-93
Kaemingk, Kris L; Carey, Marissa E; Moore, Ida M et al. (2004) Math weaknesses in survivors of acute lymphoblastic leukemia compared to healthy children. Child Neuropsychol 10:14-23
Moore, Ida M; Challinor, Julia; Pasvogel, Alice et al. (2003) Online exclusive: behavioral adjustment of children and adolescents with cancer: teacher, parent, and self-report. Oncol Nurs Forum 30:E84-91
Kaemingk, Kris L; Pasvogel, Alice E; Goodwin, James L et al. (2003) Learning in children and sleep disordered breathing: findings of the Tucson Children's Assessment of Sleep Apnea (tuCASA) prospective cohort study. J Int Neuropsychol Soc 9:1016-26